Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
Osteosarcoma (OS), the most common malignant tumor in the musculoskeletal system, mainly occurs in adolescents. OS results in high mortality and disability rates due to a fatal metastatic tendency and subsequent iatrogenic damage caused by surgery, radiotherapy and chemotherapy. Recently, immunother...
Saved in:
Main Authors: | Zeng Zhang (Author), Xin Tan (Author), Zengxin Jiang (Author), Hao Wang (Author), Hengfeng Yuan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges
by: Lu Gan, et al.
Published: (2022) -
Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023) -
Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
by: Yi-xuan Yu, et al.
Published: (2023) -
Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis
by: Hui Zhuan Tan, et al.
Published: (2022) -
Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
by: Gopalakrishnan D, et al.
Published: (2018)